GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Trading 10-06 10:51:06 EDT

46.23

-0.32

-0.69%

High47.01	Low46.18	Vol1.61M
Open46.96	D1 Closing46.55	Amplitude1.79%
Mkt Cap93.51B	Tradable Cap89.69B	Total Shares2.02B
T/O75.48M	T/O Rate0.08%	Tradable Shares1.94B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":46.23,"timestamp":1791298265407,"preClose":46.55,"halted":0,"volume":1614499,"delay":0,"changeRate":-0.006874328678839963,"floatShares":1939999999,"shares":2022697682,"eps":3.127128,"marketStatus":"Trading","change":-0.32,"latestTime":"10-06 10:51:06 EDT","open":46.96,"high":47.01,"low":46.175,"amount":75481178.33542499,"amplitude":0.017938,"askPrice":46.24,"askSize":255,"bidPrice":46.23,"bidSize":50,"shortable":3,"etf":0,"ttmEps":3.127128,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791316800000},"marketStatusCode":2,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":46.55,"dividendRate":0.039816,"preHourTrading":{"tag":"盘前","latestPrice":46.98,"preClose":46.55,"latestTime":"09:29 EDT","volume":307040,"amount":14463834.6032,"timestamp":1791293399084,"change":0.43,"changeRate":0.009237,"amplitude":0.015252},"postHourTrading":{"tag":"盘后","latestPrice":47.1338,"preClose":46.55,"latestTime":"19:58 EDT","volume":30403,"amount":1415467.5316,"timestamp":1791244703712,"change":0.5838,"changeRate":0.012541,"amplitude":0.012541},"volumeRatio":1.505041,"impliedVol":0.3176,"impliedVolPercentile":0.6494},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"1130787623","title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","url":"https://stock-news.laohu8.com/highlight/detail?id=1130787623","media":"Bellwether Stocks Movement","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1130787623?lang=en_us&edition=fundamental","pubTime":"2026-10-06 10:42","pubTimestamp":1791254527,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3157.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","MRNY","ELIS","PFE","IDNA","NVS","GILD","MRK","AMGN","NVOH","NVOX","ABT","REGN","JNJ","VERU","NVAX","VIR","NVOC","AZN","ELIL","ABBV","SNY","MRNA","XBI","LLII","SBIO","BIIB","LLYX","BMY","GERM","MRNX","GSK","DNA","NVO","LLY","GSKH"],"isVideo":true,"video":{"duration":153,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3157.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","audio_url":"https://static.tigerbbs.com/bf2704fcb2c9a829b788528d676b3500.mp3","isAI":true},"gpt_icon":0},{"id":"2673054830","title":"GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673054830","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673054830?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:42","pubTimestamp":1791294162,"startTime":"0","endTime":"0","summary":"ViiV Healthcare, which is majority owned by GSK , said Tuesday that a phase 3b study has met its primary endpoint, showing that at six months, Cabenuva saw \"superior rates of viral suppression\" compared with oral antiretroviral therapy in adults and adolescents with HIV-1, who had detectable virus when they started the trial.The trial has enrolled 326 participants in eight countries at 85 study sites, the company said.The results follow a previous trial that showed that Cabenuva was superior to daily oral therapy in keeping viral suppression for people with HIV who had reached viral suppression on oral antiretroviral therapy but had a history of adherence challenges, ViiV said.The latest trial addressed a \"remaining evidence gap by evaluating direct initiation of the regimen in people who still had detectable virus at study entry,\" the company said.ViiV said the latest results will now be shared with health regulators.Price: 46.77, Change: +0.24, Percent Change: +0.52","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LABU","BK4007","GSKH","LU0029874061.USD","BK4137","LU0128526141.USD","BK4585","XBI","BK4581","XLV","GSK","GSK.UK","LU1829250122.USD","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051943","title":"GSK’s ViiV Healthcare announces phase IIIb CROWN study met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051943","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051943?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:10","pubTimestamp":1791292244,"startTime":"0","endTime":"0","summary":"ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), with Shionogi as a shareholder, announced the phase IIIb CROWN stud...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-announces-phase-iiib-crown-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-announces-phase-iiib-crown-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4137","GSKH","BK4532","BK4585","BK4588","LABU","BK4007","LU0029874061.USD","XBI","BK4581","LU1829250122.USD","GSK.UK","XLV","GSK","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085761","title":"GSK Slides Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085761?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:09","pubTimestamp":1791216540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares dropped 1.15% to GBP17.59 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.34% to 10,497.94.GSK PLC closed 22.92% below its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.4 million, compared to the 50-day average of 6.4 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","GSK.UK","BK4585","LU1829250122.USD","BK4007","BK4588","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673832210","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2673832210","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673832210?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:12","pubTimestamp":1791213166,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.14% to 1,883.96 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by lender Banco Santander  and brewing company Anheuser-Busch InBev , which advanced 3.2% and 0.8% respectively. They were followed by 3D printer company Materialise  and internet browser company Opera , which were up 0.6% and 0.3% respectively.The decliners from continental Europe were led by biopharmaceutical company Nokia  and biopharmaceutical company Cellectis , which lost 3.2% each. They were followed by biopharmaceutical company DBV Technologies  and petroleum refiner Equinor , which decreased 0.9% and 0.4%, respectively.The gainers from the UK were led by biopharmaceutical company Bicycle Therapeutics  and software firm Endava plc , which climbed 17% and 1.6% respectively. They were followed by medical device maker Smith & Nephew  and biotech firm Trinity Biotech","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRIB","BCYC","GSIB","IE00BMPRXR70.SGD","BK4082","LU0006061336.USD","MTLS","GSKH","LFGY","CLLS","BK7142","BK4546","DBVT","GSK.UK","DAVA","IHG","EPV","SNN","EQNR","BK4023","SLN","BDRX","LU1829250122.USD","OPRA","BK4201","BUD.AU","PRNT","BUD","BK4020","BK4117","GSK","BK4547","SAN","LNOK","BK4588","IE00BMPRXN33.USD","SAN.AU","BK4521","NOK","BK4134","BK4142","BK7119","BK4207","LU0084288595.USD","AFG","BK4107","BK4585","IEUR","DAVA.AU","BK4158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165041702","title":"One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=1165041702","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165041702?lang=en_us&edition=fundamental","pubTime":"2026-10-05 15:29","pubTimestamp":1791185371,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3140.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3140.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","ABT","AMGN","JNJ","SNY","BMY","CSLLY","AZN","546.SI","GILD","1H3.SI","BIIB","A50.SI","41A.SI","BSL.SI","MRK","C2PU.SI","NVAX","H02.SI","BNTX","REGN","5NG.SI","AW9U.SI","AP4.SI","LLY","PFE","VIR","ABBV","MRNA","VERU","NVO","GSK"],"isVideo":true,"video":{"duration":217,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3140.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3140.webp","audio_url":"https://static.tigerbbs.com/035eb06a923df5523989f56e6fc14c4d.mp3","isAI":true},"gpt_icon":0},{"id":"1124786704","title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","url":"https://stock-news.laohu8.com/highlight/detail?id=1124786704","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124786704?lang=en_us&edition=fundamental","pubTime":"2026-10-05 14:41","pubTimestamp":1791182489,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3135.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","MRNY","ELIS","PFE","NVS","SDS","SPYQ","DOG","QQQ","SSO","SH","HIBL","IVV","SMAX","UPRO","GILD","YSPY","MRK","AMGN","NVOH","SPXL",".IXIC","NVOX","ABT","SPDN","SPXS","UDOW","REGN","JNJ","SPYH","JPMO","DXD","MMAX","VERU","NVAX","VIR","DMAX","NVOC","AZN","SQQQ","ELIL","ABBV",".SPX","JPM","SNY","MRNA","TQQQ",".DJI","DDM","SPYM","DIA","LLII","SPYU","BIIB","LLYX","BMY","SPY","MRNX","VOO","SPXU","GSK","NVO","SDOW","LLY","GSKH","SPUU","JPO"],"isVideo":true,"video":{"duration":182,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3135.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","audio_url":"https://static.tigerbbs.com/d492d9882b1cd5d0c5306026a8f1963f.mp3","isAI":true},"gpt_icon":0},{"id":"1157208455","title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1157208455","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157208455?lang=en_us&edition=fundamental","pubTime":"2026-10-05 10:38","pubTimestamp":1791167898,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3125.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","LLII","VERU","GSK","MRK","NVOH","MRNY","MRNX","LLYX","ABBV","NVS","NVAX","NVOC","ABT","NVO","MRNA","AMGN","BMY","CSLLY","SNY","NVOX","BNTX","BIIB","JNJ","REGN","VIR","ELIL","LLY","GSKH","GILD","PFE","ELIS"],"isVideo":true,"video":{"duration":229,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3125.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","audio_url":"https://static.tigerbbs.com/c84a44b957cb1cda4f39d165f739b07a.mp3","isAI":true},"gpt_icon":0},{"id":"1151971109","title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1151971109","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151971109?lang=en_us&edition=fundamental","pubTime":"2026-10-03 17:22","pubTimestamp":1791019366,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3081.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","MRK","ELIS","NVOH","BMY","BIIB","BAYRY","NVOX","PFE","MRNY","AZN","LLY","LLII","SNY","JNJ","GILD","NVO","MRNX","ABT","GSKH","ELIL","NVAX","NVOC","AMGN","BNTX","NVS","VIR","GSK","MRNA","REGN","VERU","LLYX"],"isVideo":true,"video":{"duration":206,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3081.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","audio_url":"https://static.tigerbbs.com/f1bbc2b54742b92aafc704bc4d0c576c.mp3","isAI":true},"gpt_icon":0},{"id":"1198460816","title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","url":"https://stock-news.laohu8.com/highlight/detail?id=1198460816","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198460816?lang=en_us&edition=fundamental","pubTime":"2026-10-03 16:06","pubTimestamp":1791014787,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3076.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","MRK","VIR","REGN","ELIS","JNJ","MRNA","LLY","GSKH","ELIL","LLYX","NVAX","MRNX","NVOH","GSK","SNY","BIIB","AMGN","AZN","NVOX","NVO","PFE","LLII","VERU","NVS","BMY","MRNY","NVOC","BNTX","ABBV","ABT"],"isVideo":true,"video":{"duration":261,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3076.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","audio_url":"https://static.tigerbbs.com/5f9a45d52af3674e966786287f89b42c.mp3","isAI":true},"gpt_icon":0},{"id":"1124840365","title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1124840365","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124840365?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932272,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3059.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","AZN","XBI","PFE","BEAM","TXG","NVOC","MRNA","GSKH","LLII","TEM","ABBV","GILD","NVO","DNA","ABT","SNY","SBIO","MRNX","VERU","GERM","REGN","JNJ","LLYX","NVOX","MRNY","AMGN","ELIL","BIIB","IDNA","NVOH","TEMT","LLY","BMY","RBOT","CRSP","ELIS","BNTX","RXRX","MRK","NVAX","NVS","ABSI","TEMC","GSK"],"isVideo":true,"video":{"duration":213,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3059.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","audio_url":"https://static.tigerbbs.com/1c89c593761ab28aabf1a552eb3a775b.mp3","isAI":true},"gpt_icon":0},{"id":"2672075260","title":"GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672075260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672075260?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:16","pubTimestamp":1790856968,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Zain Ebrahim maintained a Sell rating on GlaxoSmithKline today and set a price target of £17.00. According to TipRanks, Ebrahim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0158827781.USD","LU1548497426.USD","LU0098860793.USD","LU2133065610.SGD","LU2357305700.SGD","LU1732800096.USD","GSK.UK","LU0390134368.USD","LU0557290698.USD","GSK","LU0225283273.USD","LU1244550494.USD","LU0006306889.USD","LU0882574139.USD","BK4585","LU1668664300.SGD","LU0795875086.SGD","LU2028103732.USD","LU2089283258.USD","LU2264538146.SGD","GSKH","IE00B3S45H60.SGD","LU1791710400.SGD","LU2487616109.SGD","LU0234570918.USD","LU0106261372.USD","LU0971096721.USD","LU1791710582.SGD","LU1829250122.USD","LU0528227936.USD","LU0053666078.USD","LU0210528500.USD","LU1720051017.SGD","LU2089284900.SGD","LU2347655156.SGD","BK4127","BK4534","LU1064131342.USD","LU1244550221.USD","LU0106831901.USD","LU2023251221.USD","LU0314104364.USD","BK4504","IAI","IE00BZ1G4Q59.USD","LU0158827948.USD","LU0267386448.USD","BK4516","KBWB","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672878691","title":"GSK Slides Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672878691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672878691?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:08","pubTimestamp":1790784480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares shed 1.29% to GBP18.32 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index  falling 0.29% to 10,606.00.GSK PLC closed 19.72% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 6.3 million, compared to the 50-day average of 6.6 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GSKH","GSK","LU1829250122.USD","GSK.UK","BK4585","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671778532","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2671778532","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671778532?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:19","pubTimestamp":1790781554,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.43% to 1,911.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company DBV Technologies , which rose 5.2% and 3.4% respectively. They were followed by biopharmaceutical company Cellectis  and internet browser company Opera , which were up 2.4% and 1.3% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and biopharmaceutical company argenx , which dropped 2.2% and 1.7% respectively. They were followed by healthcare tech company Royal Philips  and lender Banco Santander , which lost 1.2% and 1% respectively.The gainers from the UK were led by biopharmaceutical company NuCana  and software firm Endava , which advanced 7.9% and 4.9% respectively. They were followed by biotech firm Autolus Therapeutics  and biopharmace","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AFG","BK4117","IE00B2B36J28.USD","SAN","GSIB","AUTL","PHG","LFGY","BK4588","GSKH","LU0109394709.USD","LU1983260115.SGD","ARGX","SAN.AU","LU0648005311.SGD","MREO","IBB","LU0084288595.USD","WPP.AU","DAVA","GSK","LU0390134368.USD","TRVG","TRIB","LU0823416689.USD","TBXU","IEUR","BK4082","BK4162","OPRA","BK4134","EPV","FMED","NCNA","IE0002141913.USD","WPP","BK4007","CLLS","PUK","SQNS","LU2324357040.USD","DAVA.AU","BK4521","BK4023","DBVT","GSK.UK","IE00BJJMRZ35.SGD","BK7142","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290809","title":"Jefferies Remains a Buy on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671290809?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:15","pubTimestamp":1790673326,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK.UK","GSKH","GSK","BK4588","LU1829250122.USD","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170528518","title":"$20 Billion In Deals And Counting: Lilly's CEO Targets The \"White Space\" Of Science For Larger M&A","url":"https://stock-news.laohu8.com/highlight/detail?id=1170528518","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170528518?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:56","pubTimestamp":1790661391,"startTime":"0","endTime":"0","summary":"","market":"uk","thumbnail":"https://static.tigerbbs.com/4c36b8cf5b09dd64e5193b66f4f8df2c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/4c36b8cf5b09dd64e5193b66f4f8df2c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"$20 Billion In Deals And Counting: Lilly's CEO Targets The \"White Space\" Of Science For Larger M&A","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","SNY","BNTX","JNJ","MRNA","GILD","MRNX","NVAX","REGN","GSKH","ELIL","AZN","GSK","VXRT","PFE","AHPI","APT","LLY","MRNY","ACOR","ELIS","LLII","LLYX"],"isVideo":true,"video":{"duration":159,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/2844.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/2844.webp","audio_url":"https://static.tigerbbs.com/81ab4162d87f55d09628c5b059c6a6fd.mp3","isAI":true},"gpt_icon":0},{"id":"1127378311","title":"AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=1127378311","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127378311?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:44","pubTimestamp":1790642670,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://static.tigerbbs.com/92728b90ee3a8a92bf786a931a559165","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/92728b90ee3a8a92bf786a931a559165"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","MRNY","ELIS","PFE","GILD","MRK","IBIO","ABT","REGN","JNJ","OCGN","VERU","NVAX","VIR","VXRT","AZN","ELIL","SNY","MRNA","SMMT","LLII","LLYX","MRNX","GSK","LLY","GSKH"],"isVideo":true,"video":{"duration":84,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/2802.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/2802.webp","audio_url":"https://static.tigerbbs.com/5b10203ee8e7af70c985cde92862eb24.mp3","isAI":true},"gpt_icon":0},{"id":"2670322426","title":"GSK Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2670322426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670322426?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:08","pubTimestamp":1790352480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares slipped 1.39% to GBP18.51 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.14% to 10,695.25.GSK PLC closed 18.89% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 4.2 million, compared to the 50-day average of 6.7 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4532","BK4588","LU1829250122.USD","GSK","GSKH","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196528349","title":"Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196528349","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196528349?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:38","pubTimestamp":1790260696,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks jumped. Moderna, Eli Lilly rose over 3%; Novavax, Pfizer rose around 2%; Merck, Novo Nordisk rose over 1%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","ABBV","BNTX","MRK","NVOH","VIR","GSK","PFE","NVO","NVOC","VERU","GSKH","BIIB","ABT","LLYX","AMGN","JNJ","NVS","NVAX","ELIL","BMY","MRNX","REGN","LLII","MRNA","ELIS","LLY","MRNY","SNY","NVOX","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669458428","title":"RBC Capital Keeps Their Hold Rating on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669458428","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669458428?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:45","pubTimestamp":1790214336,"startTime":"0","endTime":"0","summary":"In a report released on September 21, Trung Huynh from RBC Capital maintained a Hold rating on GlaxoSmithKline, with a price target of p1,975.00. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0634},{"period":"1month","weight":-0.0669},{"period":"3month","weight":-0.127},{"period":"6month","weight":-0.1886},{"period":"1year","weight":0.0738},{"period":"ytd","weight":-0.0508}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.006},{"period":"3month","weight":0.0363},{"period":"6month","weight":0.1462},{"period":"1year","weight":0.1578},{"period":"ytd","weight":0.1362}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.478261,"avgChangeRate":0.001243},{"month":3,"riseRate":0.608696,"avgChangeRate":0.019112},{"month":4,"riseRate":0.659574,"avgChangeRate":0.030828},{"month":5,"riseRate":0.404255,"avgChangeRate":-0.008644},{"month":6,"riseRate":0.595745,"avgChangeRate":0.010234},{"month":7,"riseRate":0.531915,"avgChangeRate":0.003565},{"month":8,"riseRate":0.574468,"avgChangeRate":0.00509},{"month":9,"riseRate":0.510638,"avgChangeRate":0.004965},{"month":10,"riseRate":0.510638,"avgChangeRate":0.012069},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}